Repligen | RGEN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agilent USD 39.08B 6.43B 2026-06
Align Technology USD 10.33B 1.75B 2026-09
BioMarin Pharmaceutical USD 11.15B 91M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Bruker USD 9.16B 3.66B 2026-06
Charles River Laboratories USD 10.39B 2.54B 2026-06
Danaher USD 157.81B 18.96B 2026-09
Dentsply International USD 2.13B 191M 2026-06
General Electric Aerospace USD 324.02B 65.91B 2026-09
Henry Schein USD 9.68B 1.4B 2026-06
Illumina USD 37.12B 3.64B 2026-11
IQVIA Holdings USD 48.06B 3.81B 2026-11
Mettler Toledo International USD 25.82B 278M 2026-06
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Repligen USD 9.74B 1.1B 2026-11
Revvity USD 12.69B 2.75B 2026-06
Standard Biotools USD 227M 95M 2026-11
Thermo Fisher Scientific USD 249.58B 58.93B 2026-09
Waters USD 37.24B 7.38B 2026-06
West Pharmaceutical Services USD 26.09B 730M 2026-09